3 hours Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead?The Motley Fool

Nobody can predict the future, but it’s not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug spending in the U.S. climbed more than 8% to reach $406 billion. It’s a lot but still less than one-third of the amount soaked up by…

Pfizer (PFE) · U.S.